Purchase Order 75N93023P01375
Award Date 9/22/23
Potential Completion Date 12/29/23
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
East Yaphank, NY 11967, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- CD Biosciences Inc., doing business as Creative Biomart, was awarded a $58,206 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide genotyping and sequencing services for microbiome analysis in human papillomavirus-related diseases. The contract calls for Creative Biomart to deliver the requested products and services in support of NIAID's research into the role of the microbiome in HPV-associated conditions...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to CD Biosciences Inc., doing business as Creative Biomart, for COVID-19 next-generation sequencing services. The $24,450.00 contract has a period of performance through September 20, 2022. CD Biosciences Inc. is a research product supplier and contract research organization that provides a wide range of specialized molecular biology services to federal agencies,...
- Creative Biolabs Inc. has been awarded a $18,180 purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide LPS analysis services. The contract has a period of performance from September 18, 2023 through December 31, 2023 and utilizes a firm fixed price payment structure. Work will be conducted by Creative Biolabs' division in Hamilton, Montana to support the NIH/NIAID's research efforts. No major subcontractors or set aside...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to CD Biosciences Inc., doing business as Creative Biomart, for metagenomic shotgun sequencing services. The contract has a potential value of $20,000.00 and a completion date of March 20, 2025. CD Biosciences Inc. is a research product supplier and contract research organization that has previously provided a...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Creative Biogene Inc., a self-certified small disadvantaged business, for the delivery of custom gene knockout cell lines. The potential value of the contract is $15,000.00, and the period of performance ends on August 16, 2020. Creative Biogene has a history of providing specialized biotechnology services,...
- This federal contract award for $22,360.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for gynotyping and sequencing services, with a completion date of September 17, 2024. CD Biosciences Inc., doing business as Creative Biomart, specializes in genomic sequencing, bioinformatics analysis, and other laboratory services to support research...
- CDI Laboratories Inc., doing business as CDI Laboratories, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide 12 samples of its HUPROT V4.0 Human Proteome Microarray and HUSCAN (PHIP-SEQ) assay service. The contract calls for CDI Laboratories to deliver its proteomics platform and associated sequencing capabilities to support research efforts at the NIH aimed at better understanding...
- This is a $23,990 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract is for laboratory and testing services to study protein expression in plasma samples. No set-aside was used. The contract has an ultimate completion date of September 29, 2025. Creative Biogene Inc. is a biotechnology services company that provides advanced analytical techniques, such as...
- This federal contract award is for $13,190 in laboratory testing services related to plasma protein analysis associated with circadian rhythm. The contract was awarded to Creative Biogene Inc., a self-certified small disadvantaged business located in Shirley, New York. The contract is a firm-fixed-price purchase order with a completion date of November 26, 2025. The funding agency is the National Institute on Aging, which is part of the National Institutes of Health (NIH), a civilian federal...
- This is a $15,270.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Creative Biogene Inc., a self-certified small disadvantaged business. The contract is for the provision of bovine and chicken primary epithelial cells and media, with a performance period running through February 28, 2025. This contract award does not utilize any set-aside designation. Creative Biogene has previously supported various government...
CD Biosciences Inc., doing business as Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen Division, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide creative diagnostics glycoproteins and nucleoproteins. The contract has a period of performance from September 22, 2023 through December 29, 2023, with all work to be conducted by the prime contractor in East Yaphank, New York. This purchase order is associated with the NIH's ongoing research efforts to understand infectious diseases at the molecular level and develop improved diagnostics and countermeasures.
Generated 12/17/23, 3:36 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 9/22/23 |